Investing in Europe's leading provider of AI-enabled chronic care
Pictured: Oviva’s co-founders Kai Eberhardt (CEO) and Manuel Baumann (CTO).
More than 200 million adults live with obesity and weight-related chronic conditions in Europe. Healthcare systems are strained by significant clinician shortages and a lack of access to in-person care. Oviva addresses this by offering an evidence-based, scalable, digital solution for weight-related and chronic conditions.
Oviva is the European leader in reimbursed weight-related digital care and has supported more than one million patients to date. Over the past two years, the company has tripled new patient intake, while achieving cash-flow profitability in 2025.
Kinnevik led the USD 220m Series D round with a USD 100m investment, making Kinnevik Oviva’s largest shareholder. Read more in our press release.
A conversation with Kai Eberhardt
Kinnevik’s Senior Investment Director Christian Scherrer sat down with Oviva’s co-founder and CEO Kai Eberhardt to talk about what inspired him to found the company, the uniqueness of Oviva’s approach and the company’s vision for transforming chronic care in Europe.
Learn more
